The Tumor Infiltrating Leukocyte Cell Composition Are Significant Markers for Prognostics of Radiotherapy of Rectal Cancer as Revealed by Cell Type Deconvolution

Tumor tissues consist of various types of cells including cancer stem cells, base cells, tumor infiltrated immune cells, and even new types of cancer associated cells. The tumor infiltrating cells play important roles in cancer progression and prognosis. Using present web servers and standalone tools of cell type deconvolution, including Timer, CIBERSORT, xCell, we deconvoluted the immune cell composition of microarray gene expression profiles of rectal cancer tissues collected from the rectal cancer patients before radiotherapy operation. By comparing the cell type composition obtained by timer of the rectal tissues from the radiotherapy responsive patients with those of non-responsive patients, we found that the content of CD4+ cells has average content of 0.1378 versus 0.1071 with p=0.0215; the ratio of CD4+/CD8+ is averaged 0.7869 versus 0.5564 with p=0.0210; and T cells CD4 memory resting and Eosinophils are both significantly higher with p-value of 0.033 and 0.0206, respectively, in radiotherapy responsive rectal cancer patient than in non-responsive cancer patients. The content of CD8+ cells are lower in the responsive than in non-responsive patients, which is averaged 0.1798 versus 0.2104 with p=0.0239. Other significant different cell types include macrophages M1 and M2, adipocytes, plasma cells and preadipocytes. Patients can be classified into responsive and non-responsive by machine learning method based on the tumor infiltrating immune cell composition with accuracy of 65%. It will be investigated that if the results can be applied to our newly collected data of other type of cancers including lung and nasopharyngeal carcinoma cancers in the future.

[1]  Yoko Yamamoto,et al.  Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. , 2006, Cancer research.

[2]  David Boulware,et al.  A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. , 2009, International journal of radiation oncology, biology, physics.

[3]  Steven Eschrich,et al.  Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. , 2009, International journal of radiation oncology, biology, physics.

[4]  Lian Li,et al.  Association of Intra-tumoral Infiltrating Macrophages and Regulatory T Cells Is an Independent Prognostic Factor in Gastric Cancer after Radical Resection , 2011, Annals of Surgical Oncology.

[5]  Hein Putter,et al.  FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer , 2011, Cancer Microenvironment.

[6]  T. Dønnem,et al.  CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy. , 2013, Lung cancer.

[7]  Theresia Thalhammer,et al.  Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium , 2013, BMC Cancer.

[8]  E. Gonzalez-Billalabeitia,et al.  Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer , 2014, Breast Cancer Research.

[9]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[10]  Honghao Zhou,et al.  Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment. , 2015, Carcinogenesis.

[11]  S. Adams,et al.  Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer , 2016, Current Breast Cancer Reports.

[12]  Nolan A Wages,et al.  Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies , 2016, Cancer Immunology, Immunotherapy.

[13]  Jun S. Liu,et al.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.

[14]  Judit Oláh,et al.  Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy , 2017, Cancer Immunology, Immunotherapy.

[15]  T. Shen,et al.  The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. , 2017, Human pathology.

[16]  Atul J. Butte,et al.  xCell: Digitally portraying the tissue cellular heterogeneity landscape , 2017 .

[17]  Li Kong,et al.  Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy , 2017, Cancer biology & therapy.

[18]  Jacob G. Scott,et al.  A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. , 2017, The Lancet. Oncology.

[19]  Min Zhao,et al.  The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  Min Zhu,et al.  Characterization of Radiotherapy Sensitivity Genes by Comparative Gene Set Enrichment Analysis , 2018, ICIC.

[21]  Juan Shen,et al.  Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma. , 2018, Human pathology.

[22]  Ash A. Alizadeh,et al.  Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.